Drug Manufacturers - General | Healthcare
Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the pain management, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics, upper respiratory, ear care, skincare, anticancer, anti-ulcerative, anti-allergy, antiviral, dietary, cardiac, dermatology, antihistamines, anti-fungal, anti-viral, laxatives, and cold and cough therapeutic areas. Its product portfolio includes plain, enteric-coated, and film coated tablets; soft gelatin and hard capsules; oral liquids; and ointments, as well as creams and liquids. The company provides its products to supermarkets, high street retailers, pharmacy chains, and wholesalers. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
Market Cap
114052751360
Current Price
242.05
52 Week Range
171.0 - 358.7
Previous Close
247.55
Open
248.4
Industry
Drug Manufacturers - General
Sector
Healthcare
Address
Grandeur, 11th Floor Veera Desai Extension Road Oshiwara, Andheri (West), Mumbai, 400053, India
Phone
+91-22400-12000
Fax
+91-22400-12011
Website
https://marksanspharma.com
Day Low
241.2
Day High
250.5
Dividend Yield
0.32
PE Ratio
28.849821
Earnings Per Share
8.39
Beta
1.335
EBITDA
5012740096
Book Value
54.438
EPS
10.75
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Mark B. Saldanha | Non-Independent Executive Chairman & MD | 52 | 1972 |
Mr. Jitendra M. Sharma | Group Chief Financial Officer | 55 | 1969 |
Mr. Harshavardhan Panigrahi | Company Secretary, Manager of Legal & Compliance Officer | - | - |
Ms. Sandra Saldanha | Whole-Time Executive Non Independent Director | 53 | 1971 |
Mr. Varddhman Vikramaditya Jain | Whole-Time Executive Non Independent Director | 54 | 1970 |
Mr. Vishal Bhargava | Director Operations | 53 | 1971 |
Mr. David Mohammed | Managing Director of Australia Operations | - | - |
Mr. Sunil K. Rane | Senior Vice President of QC | 55 | 1969 |
Mr. Sathish Kumar | Managing Director of UK Operations | - | - |
Mr. Anjani Kumar | Chief Operating Officer of US Operations | 63 | 1961 |
Healthcare • Drug Manufacturers - General
Healthcare • Drug Manufacturers - General
Healthcare • Drug Manufacturers - General
Healthcare • Drug Manufacturers - General
Healthcare • Drug Manufacturers - General
Healthcare • Drug Manufacturers - General
Healthcare • Drug Manufacturers - General
Healthcare • Drug Manufacturers - General
Healthcare • Drug Manufacturers - General
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.